Gracell Biotechnologies Inc.: operating_lease_liability
| Value | {"amount": 5077000, "concept": "us-gaap:OperatingLeaseLiability", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f06934f7-f7ee-4a74-9569-3444b5f470ce
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-115083Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/operating-lease-liability/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f06934f7-f7ee-4a74-9569-3444b5f470ce
History
- supersedes {"unit": "CNY", "value": 32357000, "concept": "us-gaap:OperatingLeaseLiability"} (evidence 0001193125-22-115083)